  | PAVIC, K.* , Hood, F. E.* , DUVAL, C., Manoharan, G. B., LAURINI, C., Siddiqui, F. A., Mo, S. P. L., Prior, I. A.* , & ABANKWA, D.*. (19 December 2025). Proteomics- and BRET- screens identify SPRY2 as a Ras effector that impacts its membrane organization. iScience, 28 (12), 113974. doi:10.1016/j.isci.2025.113974  Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | CHIPPALKATTI, R.* , PARISI, B.* , Kouzi, F., LAURINI, C., Ben Fredj, N., & ABANKWA, D. (June 2024). RAS isoform specific activities are disrupted by disease associated mutations during cell differentiation. European Journal of Cell Biology, 103 (2), 151425. doi:10.1016/j.ejcb.2024.151425 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | CHIPPALKATTI, R., PARISI, B., Kouzi, F., LAURINI, C., Ben Fredj, N., & ABANKWA, D. (2023). RAS isoform specific activities are disrupted by disease associated mutations during cell differentiation. Cold Spring Harbor Laboratory. doi:10.1101/2023.10.05.561021 |
 | Manoharan, G. B., LAURINI, C., BOTTONE, S., BEN FREDJ, N., & ABANKWA, D. (2023). K-Ras Binds Calmodulin-Related Centrin1 with Potential Implications for K-Ras Driven Cancer Cell Stemness. Cancers. doi:10.3390/cancers15123087 Peer Reviewed verified by ORBi |
 | CHIPPALKATTI, R.* , PARISI, B.* , YACOUB KOUZI, F., BEN FREDJ EP SOUA, N., LAURINI, C., & ABANKWA, D. (2023). A medium-throughput assay to profile the impact of Ras-disease mutants and -drugs on cellular differentiation [Paper presentation]. Tumor Heterogeneity, Plasticity and Therapy (2nd edition), Leuven, Belgium. * These authors have contributed equally to this work. |
 | OKUTACHI, S. O., MANOHARAN, G. B., Kiriazis, A., LAURINI, C., CATILLON, M., McCormick, F., Yli-Kauhaluoma, J., & ABANKWA, D. (2021). A covalent calmodulin inhibitor as a tool to study cellular mechanisms of K-Ras-driven stemness. Frontiers in Cell and Developmental Biology. doi:10.3389/fcell.2021.665673 Peer Reviewed verified by ORBi |
 | Vetter, G., Saumet, A., MOES, M., Vallar, L., LE BÉCHEC, A., LAURINI, C., Sabbah, M., Arar, K., Theillet, C., Lecellier, C.-H., & Friederich, E. (2016). miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene, 35 (5), 670. doi:10.1038/onc.2015.265 Peer reviewed |
  | LOMMEL, M., TRAIRATPHISAN, P., Gäbler, K., LAURINI, C., Muller, A., Kaoma, T., Vallar, L., SAUTER, T., & SCHAFFNER, E. (2016). L-plastin Ser5 phosphorylation in breast cancer cells and in vitro is mediated by RSK downstream of the ERK/MAPK pathway. FASEB Journal. doi:10.1096/fj.15-276311 Peer Reviewed verified by ORBi |
 | MOES, M., LE BÉCHEC, A., CRESPO, I., LAURINI, C., HALAVATYI, A., Vetter, G., DEL SOL MESA, A., & Friederich, A. (2012). A Novel Network Integrating a miRNA-203/SNAI1 Feedback Loop which Regulates Epithelial to Mesenchymal Transition. PLoS ONE, 7 (4), 35440. doi:10.1371/journal.pone.0035440 Peer Reviewed verified by ORBi |